Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $121.1900 (0.82%) ($118.2100 - $121.2700) on Mon. Feb. 4, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.68% (three month average) | RSI | 43 | Latest Price | $121.1900(0.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.2% a day on average for past five trading days. | Weekly Trend | LGND declines -0.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.84% in a week (0% probabilities). VXX(-15%) TLT(-15%) VIXM(-10%) UUP(-10%) IFRA(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.84% (StdDev 3.68%) | Hourly BBV | 0 () | Intraday Trend | 0.7% | | | |
|
Resistance Level | $122.21 | 5 Day Moving Average | $118.62(2.17%) | 10 Day Moving Average | $116.16(4.33%) | 20 Day Moving Average | $122.21(-0.83%) | To recent high | -29.2% | To recent low | 10.1% | Market Cap | $1.948b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |